CXCL8 and cholangiocarcinoma: Thus, future studies involving experiments with blocking antibodies will have to examine whether these inflammatory factors (such as MCP-1, CXCL-1, IL-6 or IL-8) are responsible for enhanced migration of CCA cells and SC, respectively.